Clinical Trial Update: Clinical Study on the Effect of Removal of Porphyromonas Gingivalis on Prognosis of Esophageal Cancer After Radical Surgery [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating whether regular removal of Porphyromonas gingivalis after radical surgery improves disease-free survival in esophageal cancer …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Snippet

Sponsor: The First Affiliated Hospital of Henan University of Science and Technology | Conditions: Evaluate the DFS of Patients With Esophageal Cancer Who Underwent Radical Operation After Regular Removal of Porphyromonas Gingivalis | Phase 3 | Status: NOT_YET_RECRUITING